Abstract:Objective To investigate the efficacy of intensity modulated radiation therapy (IMRT) combined with Temozolomide ( TMZ) and analyze prognostic factors in the treatment of thalamic gliomas .Methods The clinical data of 25 patients with thalamic gliomas who were treated by radio-chemotherapy from Jan .2005 to Dec.2010 were analyzed retrospectively .All patients were underwent biopsy to verify the pathology before the treatment , 11 were low grade gliomas ( LGG, WHO Ⅱ) and 14 high grade gliomas ( HGG,WHOⅢ-Ⅴ) .We recorded the treatment reaction and calculated the overall survival ( OS ) as well as progression free survival ( PFS ) .The prognostic factors were analyzed by using multivariate COX regression model .Results The acute treatment toxicity were mostly at grade Ⅰ to grade Ⅱ, and no grade Ⅲ or higher adverse reaction was observed .The median KPS was elevated by 20 after the end of concurrent radio-chemotherapy .The OS of 6 months, 1 and 2 years was 84.0%, 52.0%and 22.2%respectively,the PFS was 76%.0, 33.0%and 19.8%respectively.The median overall survival time was 13.0 months(95%CI 9.5-16.5) and the median progression free survival time was 9.0 months (95% CI 6.9-11.1). Multivariate analysis did not reveal the significant correlation of sex , age, duration of symptoms and pre-radiotherapy KPS with the prognosis of the patients , and the grade of histopathology correlated to the prognosis significantly .Conclusion IMRT radiotherapy combine with TMZ chemotherapy has mild and tolerable acute reaction in the treatment of unresected thalamic gliomas , and the short-term efficacy can be improved while the long-term efficacy is still unsatisfactory .

Treatment of thalamic gliomas with intensity modulated radiation therapy combine with temozolomide